Taken together, our results identify the anti-inflammatory properties in association with limited atrophogenic effects of the two novel GR ligands DE.303 and KL.202, thus providing a rationale for further investigation of their therapeutic efficacy for the treatment of inflammatory skin disorders. This evidence concerns the gene NR3C1 and inflammatory skin disease.